Patents
Patents for C07C 279 - Derivatives of guanidine, i.e. compounds containing the group the singly-bound nitrogen atoms not being part of nitro or nitroso groups (5,394)
07/2004
07/06/2004US6759420 Low molecular weight, factor xa specific blood clotting inhibitors without side effects
07/01/2004WO2004054967A1 Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity
07/01/2004CA2506685A1 Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity
06/2004
06/30/2004EP1432677A1 Novel urea oligomers, the preparation method thereof and pharmaceutical compositions containing same
06/30/2004EP1070049B1 Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors
06/30/2004EP0832875B1 Highly water-soluble metalloproteinase inhibitor
06/30/2004CN1155650C Application of aryl guanidine xanthonate as vulcanization catalyst and its preparation method
06/24/2004US20040122040 Bicyclic guanidine derivatives and therapeutic uses thereof
06/23/2004EP1430025A1 Methods and compositions for treating or preventing bacterial infection
06/23/2004EP1430024A1 Alkyl urea retinoid agonists i
06/23/2004EP1430023A1 Substituied urea retinoid agonists ii
06/23/2004EP1430018A1 Method for producing beta-alanine amides
06/22/2004US6753333 Arginine salt forms of s-(-)-9- fluoro-6,7-dihydro 8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1h,5h-benzo(i,j)quinolizine-2 -carboxylic acid, a process for their preparation and pharmaceutical formulations which are
06/17/2004US20040116428 Biguanide and dihydrotriazine derivatives
06/16/2004CN1504459A Preparing method for guanidine and guanidine salt
06/16/2004CN1153568C Compounds active at a novel position on receptor-operated calcium channel useful for treatment of neurological disorders
06/15/2004US6750369 Substituted amino acids as erythropoietin mimetics
06/15/2004US6750244 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
06/15/2004US6750224 Used to systemically and topically treat bacterial gram-positive, gram-negative and anaerobic infections, especially resistant mycobacterial infections and emerging nosocomial pathogen infections
06/10/2004WO2004048320A1 Biguanide and dihydrotriazine derivatives
06/10/2004WO2003048116A3 Esters and amides as ppar-alpha agonists ____________
06/10/2004US20040110801 Prevention of degenerative joint diseases, rheumatoid arthritis, osteoarthritis, ulcerative colitis, irritable colon and Crohn's diseas, antitumor agents; drug mixture for transdermal drug delivery, sustained release; chemical synthesis
06/09/2004CN1152871C Hydroxylamine derivative useful for enhancing molecular chaperon prodn. and the prep. thereof
06/09/2004CN1152675C IL-8 receptor antagonists
06/08/2004US6747146 Method of producing nitroguanidine- and nitroenamine derivatives
06/08/2004US6747125 Gonadotropic release hormone (gnrh ) antagonists prevents ovulation of female mammalian eggs and/or the release of steroids by the gonads; used to treat steroid-dependent tumors; agonists can be used for control of reproduction
06/08/2004US6746673 For prophylaxis and/or treatment of an autoimmune disease or rheumatoid arthritis
06/03/2004US20040106560 such as N1-L-Arginylspermidine for protecting from damage from extended ischemic/hypoxic events
06/02/2004CN1500778A Preparing method for motherwort general alkaloid
05/2004
05/27/2004US20040102418 Compounds for the treatment of inflammatory disorders
05/25/2004US6740781 Process for separating reaction mixtures and recycling quaternary salts and bases
05/25/2004US6740717 Initiator/amidine complexes, systems comprising the complexes, and polymerized compositions made therewith
05/21/2004WO2004022528A3 Arylglycine derivatives and their use as glycine transport inhibitors
05/20/2004US20040097407 Method for the synthesis of compounds of formula I and their uses thereof
05/20/2004US20040097399 Medicinal association of a biguanine and a carrier, for example metformin and arginine
05/19/2004EP1419172A2 Bi-directional synthesis of oligoguanidine transport agents
05/19/2004EP1202956B1 Therapeutically and/or nutritionally enhanced derivatives of active ingredients and orally administrable compositions containing same
05/19/2004CN1498214A Bicyclic guanidine derivatives and therapeutic uses thereof
05/13/2004US20040092599 Production process of guanidine derivative containing amido group and salt thereof
05/12/2004EP1292570B1 Creatine salt having enhanced nutritional and therapeutic efficacy and compositions containing same
05/12/2004EP1261647B1 Initiator/amidine complexes, systems comprising the complexes, and polymerized compositions made therewith
05/11/2004US6734212 Methods and compositions for treating or preventing bacterial infection
05/06/2004US20040087627 Decarboxylase inhibitors; cardiovascular diosrders; antidiabetic agents; anticancer agents; dietetics
05/05/2004CN1494424A IL-8 receptor antagonists
05/05/2004CN1148378C 15-deoxyspergualin analogs, their method of preparation and their use in therapeutics
05/04/2004US6730783 Reacting aminoguanidine with carbonyl compound to form amidinohydrazone; reduction; reacting with alkoxyamine; guanidinylation; anticoagulants
05/04/2004US6730693 Double salts of fumaric acid with a carnitine and an amino acid and food supplements, dietary supplements and drugs containing same
04/2004
04/29/2004US20040081620 Measurement anticoagulant
04/27/2004US6727393 Of quaternary salt deprotonated hydroxy aromatic acid; reactive extraction in hydroxide; circulation
04/27/2004CA2181026C Process for the preparation of creatine or creatine monohydrate
04/22/2004WO2003057164A3 Compounds for delivering substances into cells
04/22/2004US20040077902 Dicreatine maleate and method for making same
04/22/2004US20040077719 Food supplements, feed additives, dietetic, cosmetics
04/21/2004EP1409468A2 Guanidinobenzamides as mc4-r agonists
04/21/2004EP1228039B1 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
04/21/2004CN1146557C Process for prepn. of 1-type sodium-hydrogen exchange agent inhibitor
04/15/2004WO2004031133A1 Process for the synthesis of guanidine derivatives
04/15/2004US20040072880 Cycloalkyl inhibitors of potassium channel function
04/14/2004EP0839041B1 Cyclo-oxygenase inhibitor and amidine derivative salts, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing said salts
04/13/2004US6720451 Method for producing N-methyl-N′-nitroguanidine
04/08/2004WO2003084820A3 Method for protecting packed food products from spoilage during storage and package or pre-cut package for storing food products
04/08/2004US20040068013 Supplying in situ using amino acid; immobilization
04/08/2004US20040067987 Antiarthritic agents; osteoporosis; anticancer agents
04/08/2004US20040067940 Antiischemic agents; antiinflammatory agents; antiallergens; autoimmune disease
04/07/2004CN1486975A Precipitation process of extracting arginine
04/06/2004US6716436 In combination with cosmetically acceptable excipient at least one nitric oxide precursor compound which is l-arginine analogue or one of its derivatives or salts
04/06/2004CA2129430C N, n'-substituted imidocarbonimidic diamides derived from hydroxylamines
04/03/2004CA2453071A1 Genes and proteins for the production of polyene polyketides
04/01/2004US20040063791 Aminobiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions
04/01/2004US20040063790 By administering an organic peptidomimetic vibronectin receptor alpha v beta 3 antagonist of given structures
04/01/2004US20040063671 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
04/01/2004US20040062844 Adduct of amino acid and artificial sweetener
03/2004
03/31/2004CN1485317A Process for the preparation of intermediate-1,1,3,3,-tetramethyl carbamidine hydrochloride of 1,1,3,3-tetramethyl carbamidine
03/25/2004WO2003048106A3 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof
03/24/2004EP0784469B1 Compositions for the delivery of antigens
03/23/2004US6710056 Pharmaceutically acceptable salts thereof have an excellent antagonistic effect against activated blood coagulation factor vii.
03/18/2004WO2004022528A2 Arylglycine derivatives and their use as glycine transport inhibitors
03/18/2004WO2003095421A8 Amino acid analogues
03/18/2004WO2003086563A3 Diabetes imaging probes
03/18/2004US20040054212 Combretastatin A-4 phosphate prodrug mono-and di-organic amine salts, mono-and di-amino acid salts, and mono-and di-amino acid ester salts
03/17/2004EP1039890B1 Novel salts of metformin and method
03/16/2004US6706765 Aminoguanidines and alkoxyguanidines as protease inhibitors
03/11/2004WO2003034071A3 A method of forming a dynamic combinatorial library using a scaffold
03/10/2004CN1480455A 'Sqiqu site' ramification and its preparing method as well as its activity of anti asthma
03/09/2004US6703468 Composition for topical administration to skin or hair comprising suitable carrier and effective amount of specified polymer which has beneficial effects on skin functions
03/09/2004US6703042 Salts of L-carnitine and lower alkanoyl L-carnitine
03/04/2004US20040044081 Hypotensive agents; cardiovascular disorders; anticholesterol agents; antiarrhythmia agents
03/04/2004US20040044037 Sleep disorders; antidepressants; analgesics; central nervous system disorders
03/03/2004EP1392655A2 Potassium channel openers
03/03/2004CN1140506C Method for preparing guanidine derivative
02/2004
02/26/2004US20040039034 Hydroxypropyl amides for the treatment of Alzheimer's disease
02/26/2004US20040038941 Compounds for the treatment of inflammatory disorders
02/25/2004EP1390340A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
02/25/2004EP1206447B1 Selective inhibitors of the urokinase plasminogene activators
02/25/2004EP1165064B1 Novel inhibitors of formation of advanced glycation endproducts (age's)
02/18/2004EP1208078B1 Non-hygroscopic salts of active ingredients having therapeutical and/or nutritional activities and orally administrable compositions containing same
02/18/2004EP1204633B1 Method for producing 1-methyl-3-nitroguanidine
02/17/2004US6693217 Antimalarial N,N′-substituted biguanides derived from hydroxylamines
02/04/2004EP0730404B1 Amphiphilic imidazolinium derivatives
01/2004
01/29/2004US20040019216 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
1 ... 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 ... 54